Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Diseases of the Thyroid

  Free Subscription


Articles published in Cancer

Retrieve available abstracts of 56 articles:
HTML format
Text format



Single Articles


    April 2018
  1. WIRTH LJ, Tahara M, Robinson B, Francis S, et al
    Treatment-emergent hypertension and efficacy in the phase 3 Study of (E7080) lenvatinib in differentiated cancer of the thyroid (SELECT).
    Cancer. 2018 Apr 14. doi: 10.1002/cncr.31344.
    PubMed     Text format     Abstract available


    February 2018
  2. ROCHE AM, Fedewa SA, Shi LL, Chen AY, et al
    Treatment and survival vary by race/ethnicity in patients with anaplastic thyroid cancer.
    Cancer. 2018 Feb 6. doi: 10.1002/cncr.31252.
    PubMed     Text format     Abstract available


    January 2018
  3. NIKIFOROVA MN, Mercurio S, Wald AI, Barbi de Moura M, et al
    Analytical performance of the ThyroSeq v3 genomic classifier for cancer diagnosis in thyroid nodules.
    Cancer. 2018 Jan 18. doi: 10.1002/cncr.31245.
    PubMed     Text format     Abstract available


  4. WEEKS KS, Kahl AR, Lynch CF, Charlton ME, et al
    Racial/ethnic differences in thyroid cancer incidence in the United States, 2007-2014.
    Cancer. 2018 Jan 16. doi: 10.1002/cncr.31229.
    PubMed     Text format     Abstract available


    December 2017
  5. ROTH MY, Witt RL, Steward DL
    Molecular testing for thyroid nodules: Review and current state.
    Cancer. 2017 Dec 26. doi: 10.1002/cncr.30708.
    PubMed     Text format     Abstract available


    November 2017
  6. CHANDLER JB, Colunga M, Prasad ML, Callender GG, et al
    Identification of distinct cytomorphologic features in the diagnosis of NIFTP at the time of preoperative FNA: Implications for patient management.
    Cancer. 2017;125:865-875.
    PubMed     Text format     Abstract available


    October 2017
  7. ROSSI ED, Mehrotra S, Kilic AI, Toslak IE, et al
    Noninvasive follicular thyroid neoplasm with papillary-like nuclear features in the pediatric age group.
    Cancer. 2017 Oct 12. doi: 10.1002/cncy.21933.
    PubMed     Text format     Abstract available


    September 2017
  8. ZHOU H, Baloch ZW, Nayar R, Bizzarro T, et al
    Noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): Implications for the risk of malignancy (ROM) in the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC).
    Cancer. 2017 Sep 20. doi: 10.1002/cncy.21926.
    PubMed     Text format     Abstract available



  9. Researchers delve into thyroid cancer disparities in race and age: Incidence of the disease continues to grow, but at a slower rate in some groups.
    Cancer. 2017;123:3431-3432.
    PubMed     Text format    


  10. STRICKLAND KC, Howitt BE, Barletta JA, Cibas ES, et al
    Suggesting the cytologic diagnosis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP): A retrospective analysis of atypical and suspicious nodules.
    Cancer. 2017 Sep 15. doi: 10.1002/cncy.21922.
    PubMed     Text format     Abstract available


  11. MITO JK, Alexander EK, Angell TE, Barletta JA, et al
    A modified reporting approach for thyroid FNA in the NIFTP era: A 1-year institutional experience.
    Cancer. 2017 Sep 13. doi: 10.1002/cncy.21907.
    PubMed     Text format     Abstract available


  12. NGUYEN MT, Hu J, Hastings KG, Daza EJ, et al
    Thyroid cancer mortality is higher in Filipinos in the United States: An analysis using National Mortality Records from 2003 through 2012.
    Cancer. 2017 Sep 7. doi: 10.1002/cncr.30958.
    PubMed     Text format     Abstract available


    August 2017
  13. CHOI YM, Kim WG, Kwon H, Jeon MJ, et al
    Changes in standardized mortality rates from thyroid cancer in Korea between 1985 and 2015: Analysis of Korean national data.
    Cancer. 2017 Aug 17. doi: 10.1002/cncr.30943.
    PubMed     Text format     Abstract available


  14. MEDHANIE GA, Fedewa SA, Adissu H, DeSantis CE, et al
    Cancer incidence profile in sub-Saharan African-born blacks in the United States: Similarities and differences with US-born non-Hispanic blacks.
    Cancer. 2017;123:3116-3124.
    PubMed     Text format     Abstract available


    July 2017
  15. RENSHAW AA, Gould EW
    Adequate sampling of multiple thyroid nodules by fine-needle aspiration.
    Cancer. 2017 Jul 31. doi: 10.1002/cncy.21904.
    PubMed     Text format     Abstract available


  16. OHORI NP, Wolfe J, Carty SE, Yip L, et al
    The influence of the noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) resection diagnosis on the false-positive thyroid cytology rate relates to quality assurance thresholds and the application of NIFTP criteria.
    Cancer. 2017 Jul 5. doi: 10.1002/cncy.21892.
    PubMed     Text format     Abstract available


  17. MARINA NM, Liu Q, Donaldson SS, Sklar CA, et al
    Longitudinal follow-up of adult survivors of Ewing sarcoma: A report from the Childhood Cancer Survivor Study.
    Cancer. 2017;123:2551-2560.
    PubMed     Text format     Abstract available


  18. LEWIS DR, Chen HS, Cockburn MG, Wu XC, et al
    Early estimates of SEER cancer incidence, 2014.
    Cancer. 2017;123:2524-2534.
    PubMed     Text format     Abstract available


    June 2017
  19. SHERMAN EJ, Dunn LA, Ho AL, Baxi SS, et al
    Phase 2 study evaluating the combination of sorafenib and temsirolimus in the treatment of radioactive iodine-refractory thyroid cancer.
    Cancer. 2017 Jun 29. doi: 10.1002/cncr.30861.
    PubMed     Text format     Abstract available


  20. CHO M, Oweity T, Brandler TC, Fried K, et al
    Distinguishing parathyroid and thyroid lesions on ultrasound-guided fine-needle aspiration: A correlation of clinical data, ancillary studies, and molecular analysis.
    Cancer. 2017 Jun 16. doi: 10.1002/cncy.21888.
    PubMed     Text format     Abstract available


  21. ROSSI ED, Martini M, Cenci T, Capodimonti S, et al
    The role of thyroid FNA cytology in pediatric malignant lesions: An overview of the literature.
    Cancer. 2017 Jun 5. doi: 10.1002/cncy.21884.
    PubMed     Text format     Abstract available


  22. ONENERK AM, Pusztaszeri MP, Canberk S, Faquin WC, et al
    Triage of the indeterminate thyroid aspirate: What are the options for the practicing cytopathologist?
    Cancer. 2017;125.
    PubMed     Text format     Abstract available


    May 2017
  23. HANG JF, Westra WH, Cooper DS, Ali SZ, et al
    The impact of noninvasive follicular thyroid neoplasm with papillary-like nuclear features on the performance of the Afirma gene expression classifier.
    Cancer. 2017 May 24. doi: 10.1002/cncy.21879.
    PubMed     Text format     Abstract available


  24. GOEPFERT RP, Hutcheson KA, Lewin JS, Desai NG, et al
    Complications, hospital length of stay, and readmission after total laryngectomy.
    Cancer. 2017;123:1760-1767.
    PubMed     Text format     Abstract available


  25. SHIELD PW, Frost F, Finnimore JL, Wright RG, et al
    External quality assurance in nongynecologic cytology: The Australasian experience.
    Cancer. 2017;125:349-361.
    PubMed     Text format     Abstract available


    April 2017
  26. SHAH BR, Griffiths R, Hall SF
    Thyroid cancer incidence among Asian immigrants to Ontario, Canada: a population-based cohort study.
    Cancer. 2017 Apr 25. doi: 10.1002/cncr.30746.
    PubMed     Text format     Abstract available


  27. VIVERO M, Renshaw AA, Krane JF
    Adequacy criteria for thyroid FNA evaluated by ThinPrep slides only.
    Cancer. 2017 Apr 7. doi: 10.1002/cncy.21858.
    PubMed     Text format     Abstract available


  28. BONGIOVANNI M, Mermod M, Canberk S, Saglietti C, et al
    Columnar cell variant of papillary thyroid carcinoma: Cytomorphological characteristics of 11 cases with histological correlation and literature review.
    Cancer. 2017 Apr 3. doi: 10.1002/cncy.21860.
    PubMed     Text format     Abstract available


  29. SABRA MM, Sherman EJ, Tuttle RM
    Tumor volume doubling time of pulmonary metastases predicts overall survival and can guide the initiation of multikinase inhibitor therapy in patients with metastatic, follicular cell-derived thyroid carcinoma.
    Cancer. 2017 Apr 3. doi: 10.1002/cncr.30690.
    PubMed     Text format     Abstract available


    March 2017
  30. BRANDLER TC, Zhou F, Liu CZ, Cho M, et al
    Can noninvasive follicular thyroid neoplasm with papillary-like nuclear features be distinguished from classic papillary thyroid carcinoma and follicular adenomas by fine-needle aspiration?
    Cancer. 2017 Mar 10. doi: 10.1002/cncy.21848.
    PubMed     Text format     Abstract available


    February 2017
  31. ZHAO L, Dias-Santagata D, Sadow PM, Faquin WC, et al
    Cytological, molecular, and clinical features of noninvasive follicular thyroid neoplasm with papillary-like nuclear features versus invasive forms of follicular variant of papillary thyroid carcinoma.
    Cancer. 2017 Feb 13. doi: 10.1002/cncy.21839.
    PubMed     Text format     Abstract available


  32. GAN TR, Nga ME, Lum JH, Wong WM, et al
    Thyroid cytology-nuclear versus architectural atypia within the "Atypia of undetermined significance/follicular lesion of undetermined significance" Bethesda category have significantly different rates of malignancy.
    Cancer. 2017 Feb 13. doi: 10.1002/cncy.21823.
    PubMed     Text format     Abstract available


  33. OHORI NP, Seethala RR, Nikiforov YE
    Young Investigator Challenge: Molecular testing in noninvasive follicular thyroid neoplasm with papillary-like nuclear features.
    Cancer. 2017 Feb 7. doi: 10.1002/cncy.21830.
    PubMed     Text format    


  34. JIANG XS, Harrison GP, Datto MB
    Reply to Young Investigator Challenge: Molecular testing in noninvasive follicular thyroid neoplasm with papillary-Like nuclear features.
    Cancer. 2017 Feb 7. doi: 10.1002/cncy.21829.
    PubMed     Text format    


  35. BACA SC, Wong KS, Strickland KC, Heller HT, et al
    Qualifiers of atypia in the cytologic diagnosis of thyroid nodules are associated with different Afirma gene expression classifier results and clinical outcomes.
    Cancer. 2017 Feb 2. doi: 10.1002/cncy.21827.
    PubMed     Text format     Abstract available


  36. WANG H, Hoda RS, Faquin W, Rossi ED, et al
    FNA biopsy of secondary nonlymphomatous malignancies in salivary glands: A multi-institutional study of 184 cases.
    Cancer. 2017;125:91-103.
    PubMed     Text format     Abstract available


    December 2016
  37. PEZZI TA, Mohamed AS, Sheu T, Blanchard P, et al
    Radiation therapy dose is associated with improved survival for unresected anaplastic thyroid carcinoma: Outcomes from the National Cancer Data Base.
    Cancer. 2016 Dec 27. doi: 10.1002/cncr.30493.
    PubMed     Text format     Abstract available


    November 2016
  38. JIANG XS, Harrison GP, Datto MB
    Young investigator challenge: Molecular testing in noninvasive follicular thyroid neoplasm with papillary-like nuclear features.
    Cancer. 2016 Nov 28. doi: 10.1002/cncy.21802.
    PubMed     Text format     Abstract available


  39. SOMNAY YR, Yu XM, Lloyd RV, Leverson G, et al
    Notch3 expression correlates with thyroid cancer differentiation, induces apoptosis, and predicts disease prognosis.
    Cancer. 2016 Nov 2. doi: 10.1002/cncr.30403.
    PubMed     Text format     Abstract available


    October 2016
  40. SAMIR AE
    The role and value of ultrasound elastography in the evaluation of thyroid nodules.
    Cancer. 2016 Oct 25. doi: 10.1002/cncy.21782.
    PubMed     Text format    


  41. HAUGEN BR
    2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: What is new and what has changed?
    Cancer. 2016 Oct 14. doi: 10.1002/cncr.30360.
    PubMed     Text format     Abstract available


    September 2016
  42. BIZZARRO T, Martini M, Capodimonti S, Straccia P, et al
    Young investigator challenge: The morphologic analysis of noninvasive follicular thyroid neoplasm with papillary-like nuclear features on liquid-based cytology: Some insights into their identification.
    Cancer. 2016 Sep 26. doi: 10.1002/cncy.21777.
    PubMed     Text format     Abstract available


  43. BELLEVICINE C, Sgariglia R, Malapelle U, Vigliar E, et al
    Young investigator challenge: Can the Ion AmpliSeq Cancer Hotspot Panel v2 be used for next-generation sequencing of thyroid FNA samples?
    Cancer. 2016 Sep 26. doi: 10.1002/cncy.21780.
    PubMed     Text format     Abstract available


    August 2016
  44. SHERMAN SI, Clary DO, Elisei R, Schlumberger MJ, et al
    Correlative analyses of RET and RAS mutations in a phase 3 trial of cabozantinib in patients with progressive, metastatic medullary thyroid cancer.
    Cancer. 2016 Aug 15. doi: 10.1002/cncr.30252.
    PubMed     Text format     Abstract available


  45. LUBITZ CC, Sosa JA
    The changing landscape of papillary thyroid cancer: Epidemiology, management, and the implications for patients.
    Cancer. 2016 Aug 12. doi: 10.1002/cncr.30201.
    PubMed     Text format     Abstract available


    March 2016
  46. SONG YS, Lim JA, Choi H, Won JK, et al
    Prognostic effects of TERT promoter mutations are enhanced by coexistence with BRAF or RAS mutations and strengthen the risk prediction by the ATA or TNM staging system in differentiated thyroid cancer patients.
    Cancer. 2016 Mar 11. doi: 10.1002/cncr.29934.
    PubMed     Text format     Abstract available


  47. ARMENIAN SH, Bhatia S
    Looking back to inform the future: Lesson learned from survivors of childhood cancer.
    Cancer. 2016;122:678-80.
    PubMed     Text format    


  48. FRIEDMAN DN, Chou JF, Oeffinger KC, Kleinerman RA, et al
    Chronic medical conditions in adult survivors of retinoblastoma: Results of the Retinoblastoma Survivor Study.
    Cancer. 2016;122:773-81.
    PubMed     Text format     Abstract available


    January 2016
  49. PRASAD ML, Vyas M, Horne MJ, Virk RK, et al
    NTRK fusion oncogenes in pediatric papillary thyroid carcinoma in northeast United States.
    Cancer. 2016 Jan 19. doi: 10.1002/cncr.29887.
    PubMed     Text format     Abstract available


    November 2015
  50. JIN LX, Moley JF
    Surgery for lymph node metastases of medullary thyroid carcinoma: A review.
    Cancer. 2015 Nov 5. doi: 10.1002/cncr.29761.
    PubMed     Text format     Abstract available


    October 2015
  51. WANG W, Su X, He K, Wang Y, et al
    Comparison of the clinicopathologic features and prognosis of bilateral versus unilateral multifocal papillary thyroid cancer: An updated study with more than 2000 consecutive patients.
    Cancer. 2015 Oct 27. doi: 10.1002/cncr.29689.
    PubMed     Text format     Abstract available


    August 2015
  52. WANG LY, Roman BR, Migliacci JC, Palmer FL, et al
    Cost-effectiveness analysis of papillary thyroid cancer surveillance.
    Cancer. 2015 Aug 17. doi: 10.1002/cncr.29633.
    PubMed     Text format     Abstract available


    July 2015
  53. SAWKA AM, Straus S, Rodin G, Heus L, et al
    Thyroid cancer patient perceptions of radioactive iodine treatment choice: Follow-up from a decision-aid randomized trial.
    Cancer. 2015 Jul 20. doi: 10.1002/cncr.29548.
    PubMed     Text format     Abstract available


    June 2015
  54. CASTRO MR, Morris JC, Ryder M, Brito JP, et al
    Most patients with a small papillary thyroid carcinoma enjoy an excellent prognosis and may be managed with minimally invasive therapy or active surveillance.
    Cancer. 2015 Jun 16. doi: 10.1002/cncr.29468.
    PubMed     Text format    


  55. NILUBOL N, Kebebew E
    Reply to most patients with a small papillary thyroid carcinoma enjoy an excellent prognosis and may be managed with minimally invasive therapy or active surveillance.
    Cancer. 2015 Jun 16. doi: 10.1002/cncr.29467.
    PubMed     Text format    


    May 2015
  56. ZHANG M, Qureshi AA, Fortner RT, Hankinson SE, et al
    Teenage acne and cancer risk in US women: A prospective cohort study.
    Cancer. 2015;121:1681-7.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diseases of the Thyroid is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: